P. Eifel
Journal of Clinical Oncology · 2001–2019
A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Who trusts P. Eifel overall
Papers from P. Eifel's perspective
Ordered by how strongly the researchers P. Eifel trusts endorse each paper. Same corpus, a different order for every researcher.
- The Statistical Analysis of Failure Time Data (Technometrics)
- Nonparametric Estimation from Incomplete Observations
- Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. (Journal of the American Medical Association (JAMA))
- BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. (Human Molecular Genetics)
- Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. (New England Journal of Medicine)
- Estimated risks of radiation-induced fatal cancer from pediatric CT. (AJR. American journal of roentgenology)
- Radiation Dose Associated with Common Computed Tomography Examinations and the Associated Lifetime Attributable Risk of Cancer (Archives of Internal Medicine)
- The decrease in breast-cancer incidence in 2003 in the United States. (New England Journal of Medicine)
- THE UF FAMILY OF REFERENCE HYBRID PHANTOMS FOR COMPUTATIONAL RADIATION DOSIMETRY (Physics in Medicine and Biology)
- Computed tomography--an increasing source of radiation exposure. (New England Journal of Medicine)
Their papers
- Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. (2019) — 933 citations
- Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. (2008) — 890 citations
- Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. (2004) — 1,011 citations
- National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. (2001) — 908 citations